Everything you need to know about the NHS genomic medicine service A closer look at the progress made so far on NHS England’s new national genomic medicine service.…
More than a quarter of patients overusing rescue inhalers for asthma, study finds Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
Ministers need a new approach to generic medicines Despite underpinning the fight against COVID-19, generic and biosimilar medicines do not get the attention they deserve from the UK government.…
Pharmacists advised not to send medication direct to Ukraine The Guild of Healthcare Pharmacists is advising members and healthcare workers to make financial donations instead.…
How switching a handful of patients’ inhalers saved nearly 5,000kgCO2e While switching inhalers may not be for everyone, reviewing patients who may benefit from a lower carbon device could have an enormous impact.…
Millions of patients with rare diseases to benefit from faster treatment access NHS England and NHS Improvement have committed to several actions to support faster access to medicines for people with rare diseases and conditions.…
Government misses consultation deadline for post-Brexit scheme to detect fake medicines The UK government aimed to issue a public consultation on a national falsified medicine scheme within 12 months of enacting the Medicines and Medical Devices Act on 11 February 2021.…
Some patients switched to ‘greener’ inhalers without consultation, say experts Exclusive: Experts warn that non-consented inhaler switches pose risks to patients' health and advise physicians to carry out individual inhaler checks to avoid this.…
Spike in price concessions prompts concern over generic medicine supply issues Exclusive: As the number of price concessions for generic drugs soared in January 2022, the Pharmaceutical Services Negotiating Committees has raised concerns with the government over supply issues.…